Intratumor heterogeneity and tissue distribution of KRAS mutation in non-small cell lung cancer: implications for detection of mutated KRAS oncogene in exhaled breath condensate

Presence of cancer-associated mutations in exhaled breath condensates of healthy individuals by next generation sequencing

(2017) Omar Youssef et al.   Oncotarget

Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX® HS, a new highly sensitive assay for the MassARRAY® System

(2017) Bobbie C. Sutton et al.   PLoS One

Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial

(2015) E. Rulli et al.   ANNALS OF ONCOLOGY

The Stage Classification of Lung Cancer

(2013) Frank C. Detterbeck et al.   CHEST

Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non-Small Cell Lung Cancer

(2013) S. Cardarella et al.   CLINICAL CANCER RESEARCH

Tumor Heterogeneity Revealed byKRAS,BRAF, andPIK3CAPyrosequencing:KRASandPIK3CAIntratumor Mutation Profile Differences and Their Therapeutic Implications

(2013) Vivian Kosmidou et al.   HUMAN MUTATION

Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice

(2013) Norihiro Yamaguchi et al.   LUNG CANCER

KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies

(2013) M.K.H. Maus et al.   LUNG CANCER

Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer

(2013) Ping Xiao et al.   LUNG CANCER

Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer

(2013) Hua Bai et al.   PLoS One

Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer

(2013) Sylvia Si Yang Ai et al.   RESPIRATORY MEDICINE

EGFR,KRAS,BRAF, andHER-2molecular status in brain metastases from 77 NSCLC patients

(2013) Claire Villalva et al.   Cancer Medicine

Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers

(2012) S. Dogan et al.   CLINICAL CANCER RESEARCH

Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer

(2012) Winfried H. Alsdorf et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Hotspot oncomutations: implications for personalized cancer treatment

(2012) Meagan B Myers et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Enhanced Exhalation of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Patients with COPD Exacerbation: A Prospective Study

(2012) S. Kwiatkowska et al.   RESPIRATION

Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene

(2012) Jacek Kordiak et al.   RESPIRATORY MEDICINE

Exhaled Breath Condensate: A Promising Source for Biomarkers of Lung Disease

(2012) Yan Liang et al.   TheScientificWorldJOURNAL

EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma

(2012) Alexander J. J. Smits et al.   CELLULAR ONCOLOGY

Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice

(2011) Leina Sun et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Breath analysis of hydrogen peroxide as a diagnostic tool

(2010) Robert Stolarek et al.   CLINICA CHIMICA ACTA

Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients

(2010) Giovanna E. Carpagnano et al.   LUNG CANCER

KRAS gene mutations in lung cancer: Particulars established and issues unresolved

(2010) Koji Okudela et al.   PATHOLOGY INTERNATIONAL

EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases

(2009) K. Schmid et al.   CLINICAL CANCER RESEARCH